Ann MarieMauerAnn Marie Mauer41.78927490000000-87.601250000000001277Mauer, Ann Marieprns:coAuthorOfcoauthor ofprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:physicalNeighborOfphysical neighborprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:similarTosimilar toprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierAddressvivo:addressCitycityvivo:addressPostalCodepostal codevivo:addressStatestate or provincevivo:authorInAuthorshipselected publicationsvivo:authorRankauthor rank in publicationAuthorshipDepartmentvivo:hasResearchArearesearch areasvivo:hrJobTitleHR job titleInformation Resourcevivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:mailingAddressmailing addressvivo:personInPositionpositionsPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonAuthorship 1006351Authorship 1006493Authorship 1015415Authorship 1016103Authorship 1001842Authorship 100801627944519Seiwert TY, Connell PP, Mauer AM, Hoffman PC, George CM, Szeto L, Obasaju C, Haraf DJ, Salgia R, Vokes EEJournal of clinical oncology : official journal of the American Society of Clinical OncologyA phase I dose-escalating study of combination pemetrexed-based chemotherapy and concomitant radiotherapy for locally advanced or metastatic non-small cell lung or esophageal cancer. J Clin Oncol. 2005 Jun; 23(16_suppl):7062.J Clin Oncol2005-06-01T00:00:002005A phase I dose-escalating study of combination pemetrexed-based chemotherapy and concomitant radiotherapy for locally advanced or metastatic non-small cell lung or esophageal cancer.27944957Mauer AM, Szeto L, Belt RJ, Schwartzberg LS, Hagey A, Coates AI, Meek KA, Cernohous P, Gordon GBJournal of clinical oncology : official journal of the American Society of Clinical OncologyPreliminary results of a phase 2 study of ABT-751 in patients (pts) with taxane-refractory non-small cell lung carcinoma (NSCLC). J Clin Oncol. 2005 Jun; 23(16_suppl):7137.J Clin Oncol2005-06-01T00:00:002005Preliminary results of a phase 2 study of ABT-751 in patients (pts) with taxane-refractory non-small cell lung carcinoma (NSCLC).27945465Vokes EE, Cohen EE, Mauer AM, Karrison TG, Wong SJ, Skoog-Sluman LJ, Kozloff MF, Dancey J, Dekker AJournal of clinical oncology : official journal of the American Society of Clinical OncologyA phase I study of erlotinib and bevacizumab for recurrent or metastatic squamous cell carcinoma of the head and neck (HNC). J Clin Oncol. 2005 Jun; 23(16_suppl):5504.J Clin Oncol2005-06-01T00:00:002005A phase I study of erlotinib and bevacizumab for recurrent or metastatic squamous cell carcinoma of the head and neck (HNC).27945467Cohen EE, Haraf DJ, Stenson KM, Blair E, Brockstein BE, Mauer AM, Dekker A, Williams R, Lester E, Vokes EEJournal of clinical oncology : official journal of the American Society of Clinical OncologyIntegration of gefitinib (G), into a concurrent chemoradiation (CRT) regimen followed by G adjuvant therapy in patients with locally advanced head and neck cancer (HNC) - a Phase II Trial. J Clin Oncol. 2005 Jun; 23(16_suppl):5506.J Clin Oncol2005-06-01T00:00:002005Integration of gefitinib (G), into a concurrent chemoradiation (CRT) regimen followed by G adjuvant therapy in patients with locally advanced head and neck cancer (HNC) - a Phase II Trial.27944213Hoffman PC, Mauer AM, Haraf DC, Lester EP, Szeto LL, Vokes EEJournal of clinical oncology : official journal of the American Society of Clinical OncologyA phase I study of erlotinib in combination with chemoradiation (CRT) for unresectable, locally advanced non-small cell lung cancer (NSCLC). J Clin Oncol. 2005 Jun; 23(16_suppl):7113.J Clin Oncol2005-06-01T00:00:002005A phase I study of erlotinib in combination with chemoradiation (CRT) for unresectable, locally advanced non-small cell lung cancer (NSCLC).27944528Villaflor VM, Buckingham L, Gale M, Coon J, Mauer AM, Muzzafar T, Kaiser K, Zusag TW, Faber LP, Bonomi PJournal of clinical oncology : official journal of the American Society of Clinical OncologyEGFR mutations and pAKT expression as potential predictors of gefitinib efficacy in non-small cell lung cancer (NSCLC) patients (pts). J Clin Oncol. 2005 Jun; 23(16_suppl):7077.J Clin Oncol2005-06-01T00:00:002005EGFR mutations and pAKT expression as potential predictors of gefitinib efficacy in non-small cell lung cancer (NSCLC) patients (pts).D000971Procedures30624340.47627Antineoplastic Combined Chemotherapy ProtocolsD002289Disorders15810730.519185Carcinoma, Non-Small-Cell LungRadiation and Cellular OncologyJessicaDoningtonJessica Donington41.7886000000000087.598699999999993697Donington, JessicaProfessorMedicine-Hospital MedicineAuthorship 112085Authorship 125604Authorship 139292Authorship 149782Authorship 142611Authorship 145203Authorship 149542Authorship 150342Authorship 150522Authorship 168294Authorship 164953Authorship 139463Authorship 194924Authorship 174382Authorship 220312Authorship 201342Authorship 241713Authorship 207663Authorship 253443Authorship 234253Authorship 224521Authorship 223062Authorship 131802731339827Muss HB, Polley MC, Berry DA, Liu H, Cirrincione CT, Theodoulou M, Mauer AM, Kornblith AB, Partridge AH, Dressler LG, Cohen HJ, Kartcheske PA, Perez EA, Wolff AC, Gralow JR, Burstein HJ, Mahmood AA, Sutton LM, Magrinat G, Parker BA, Hart RD, Grenier D, Hurria A, Jatoi A, Norton L, Hudis CA, Winer EP, Carey LJournal of clinical oncology : official journal of the American Society of Clinical OncologyRandomized Trial of Standard Adjuvant Chemotherapy Regimens Versus Capecitabine in Older Women With Early Breast Cancer: 10-Year Update of the CALGB 49907 Trial. J Clin Oncol. 2019 09 10; 37(26):2338-2348.J Clin Oncol2019-07-24T00:00:002019Randomized Trial of Standard Adjuvant Chemotherapy Regimens Versus Capecitabine in Older Women With Early Breast Cancer: 10-Year Update of the CALGB 49907 Trial.Authorship 194913Authorship 264292Authorship 2802Authorship 3016D008175Disorders32822600.404557Lung NeoplasmsAuthorship 271801Authorship 313403Authorship 315041Authorship 352201Authorship 320357Authorship 260242Authorship 318272Authorship 359492Authorship 342868Authorship 364922Authorship 60013Authorship 63254Authorship 373112Authorship 69043Authorship 7403Authorship 48491Authorship 380945Authorship 54431Authorship 38851Authorship 68573Authorship 422632Authorship 811410Authorship 82422Authorship 63512Authorship 65621Authorship 83578Authorship 8651Authorship 69752Authorship 65563Authorship 72973Authorship 213525Authorship 239517Authorship 248872Authorship 284627Authorship 3023Authorship 330666Authorship 3387411Authorship 47005Authorship 82639Authorship 890728388920Miller AA, Tolley EA, Niell HB, Griffin JP, Mauer AMJournal of clinical oncology : official journal of the American Society of Clinical OncologyPharmacodynamics of prolonged oral etoposide in patients with advanced non-small-cell lung cancer. J Clin Oncol. 1993 Jun; 11(6):1179-88.J Clin Oncol1993-06-01T00:00:001993Pharmacodynamics of prolonged oral etoposide in patients with advanced non-small-cell lung cancer.9331125Vokes EE, Mauer AM, Hoffman PC, Masters G, Watson S, Golomb HMSeminars in oncologyPaclitaxel/carboplatin plus ifosfamide in non-small cell lung cancer. Semin Oncol. 1997 Aug; 24(4 Suppl 12):S12-67-S12-69.Semin Oncol1997-08-01T00:00:001997Paclitaxel/carboplatin plus ifosfamide in non-small cell lung cancer.8826961Lauria MM, Hockenberry-Eaton M, Pawletko TM, Mauer AMCancerPsychosocial protocol for childhood cancer. A conceptual model. Cancer. 1996 Sep 15; 78(6):1345-56.Cancer1996-09-15T00:00:001996Psychosocial protocol for childhood cancer. A conceptual model.9440738Mauer AM, Masters GA, Haraf DJ, Hoffman PC, Watson SM, Golomb HM, Vokes EEJournal of clinical oncology : official journal of the American Society of Clinical OncologyPhase I study of docetaxel with concomitant thoracic radiation therapy. J Clin Oncol. 1998 Jan; 16(1):159-64.J Clin Oncol1998-01-01T00:00:001998Phase I study of docetaxel with concomitant thoracic radiation therapy.9335521Vokes EE, Masters GA, Mauer AM, Haraf DJ, Hoffman PC, Golomb HMSeminars in oncologyClinical studies of docetaxel (Taxotere) and concomitant chest therapy. Semin Oncol. 1997 Aug; 24(4 Suppl 14):S14-26-S14-29.Semin Oncol1997-08-01T00:00:001997Clinical studies of docetaxel (Taxotere) and concomitant chest therapy.9681085Masters GA, Mauer AM, Hoffman PC, Wyka D, Samuels BL, Krauss SA, Watson S, Golomb H, Vokes EEAnnals of oncology : official journal of the European Society for Medical OncologyA phase I-II study of paclitaxel, ifosfamide, and vinorelbine with filgrastim (rhG-CSF) support in advanced non-small-cell lung cancer. Ann Oncol. 1998 Jun; 9(6):677-80.Ann Oncol1998-06-01T00:00:001998A phase I-II study of paclitaxel, ifosfamide, and vinorelbine with filgrastim (rhG-CSF) support in advanced non-small-cell lung cancer.9689980Vokes EE, Mauer AMThe cancer journal from Scientific AmericanMultimodality therapy for esophageal cancer: an emerging role. Cancer J Sci Am. 1998 Jul-Aug; 4(4):226-9.Cancer J Sci Am1998-07-01T00:00:001998Multimodality therapy for esophageal cancer: an emerging role.10611626Flamholz R, Tran T, Grad GI, Mauer AM, Olopade OI, Ellman MH, McKinsey JF, Jeon HR, Baron JM, Baron BWJournal of clinical apheresisTherapeutic plasma exchange for the acute management of the catastrophic antiphospholipid syndrome: beta(2)-glycoprotein I antibodies as a marker of response to therapy. J Clin Apher. 1999; 14(4):171-6.J Clin Apher1999-01-01T00:00:001999Therapeutic plasma exchange for the acute management of the catastrophic antiphospholipid syndrome: beta(2)-glycoprotein I antibodies as a marker of response to therapy.9535207Vokes EE, Masters GA, Mauer AM, Hoffman PC, Watson S, Golomb HMSeminars in oncologyIfosfamide-based three-drug combination regimens in non-small cell lung cancer. Semin Oncol. 1998 Feb; 25(1 Suppl 2):19-22.Semin Oncol1998-02-01T00:00:001998Ifosfamide-based three-drug combination regimens in non-small cell lung cancer.9708952Haase GM, Mauer AM, Reaman GHCancerSurvivorship in childhood cancer: a case statement for enhancement of the role of the American Cancer Society. Task Force on Children and Cancer of the American Cancer Society. Cancer. 1998 Aug 15; 83(4):821-3.Cancer1998-08-15T00:00:001998Survivorship in childhood cancer: a case statement for enhancement of the role of the American Cancer Society. Task Force on Children and Cancer of the American Cancer Society.11561689George CM, Haraf DJ, Mauer AM, Krauss SA, Hoffman PC, Rudin CM, Szeto L, Vokes EEInvestigational new drugsA phase I trial of the oral platinum analogue JM216 with concomitant radiotherapy in advanced malignancies of the chest. Invest New Drugs. 2001; 19(4):303-10.Invest New Drugs2001-01-01T00:00:002001A phase I trial of the oral platinum analogue JM216 with concomitant radiotherapy in advanced malignancies of the chest.11561694Vokes EE, Gordon GS, Rudin CM, Mauer AM, Watson S, Krauss S, Arrieta R, Golomb HM, Hoffman PCInvestigational new drugsA phase II trial of 9-aminocaptothecin (9-AC) as a 120-h infusion in patients with non-small cell lung cancer. Invest New Drugs. 2001; 19(4):329-33.Invest New Drugs2001-01-01T00:00:002001A phase II trial of 9-aminocaptothecin (9-AC) as a 120-h infusion in patients with non-small cell lung cancer.10504119Shammo JM, Calhoun B, Mauer AM, Hoffman PC, Baron JM, Baron BWTransfusionFirst two cases of immune hemolytic anemia associated with ceftizoxime. Transfusion. 1999 Aug; 39(8):838-44.Transfusion1999-08-01T00:00:001999First two cases of immune hemolytic anemia associated with ceftizoxime.10841143Hoffman PC, Mauer AM, Vokes EELancet (London, England)Lung cancer. Lancet. 2000 Feb 05; 355(9202):479-85.Lancet2000-02-05T00:00:002000Lung cancer.12367795Hoffman PC, Cohen EE, Masters GA, Haraf DJ, Mauer AM, Rudin CM, Krauss SA, Huo D, Vokes EELung cancer (Amsterdam, Netherlands)Carboplatin plus vinorelbine with concomitant radiation therapy in advanced non-small cell lung cancer: a phase I study. Lung Cancer. 2002 Oct; 38(1):65-71.Lung Cancer2002-10-01T00:00:002002Carboplatin plus vinorelbine with concomitant radiation therapy in advanced non-small cell lung cancer: a phase I study.11843253Eng C, Mauer AM, Fleming GF, Bertucci D, Rotmensch J, Jacobs RH, Ratain MJAnnals of oncology : official journal of the European Society for Medical OncologyPhase I study of pegylated liposomal doxorubicin, paclitaxel, and cisplatin in patients with advanced solid tumors. Ann Oncol. 2001 Dec; 12(12):1743-7.Ann Oncol2001-12-01T00:00:002001Phase I study of pegylated liposomal doxorubicin, paclitaxel, and cisplatin in patients with advanced solid tumors.14122792KRILL CE, SMITH HD, MAUER AMThe New England journal of medicineCHRONIC IDIOPATHIC GRANULOCYTOPENIA. N Engl J Med. 1964 May 07; 270:973-9.N Engl J Med1964-05-07T00:00:001964CHRONIC IDIOPATHIC GRANULOCYTOPENIA.12056703Rudin CM, Otterson GA, Mauer AM, Villalona-Calero MA, Tomek R, Prange B, George CM, Szeto L, Vokes EEAnnals of oncology : official journal of the European Society for Medical OncologyA pilot trial of G3139, a bcl-2 antisense oligonucleotide, and paclitaxel in patients with chemorefractory small-cell lung cancer. Ann Oncol. 2002 Apr; 13(4):539-45.Ann Oncol2002-04-01T00:00:002002A pilot trial of G3139, a bcl-2 antisense oligonucleotide, and paclitaxel in patients with chemorefractory small-cell lung cancer.12702526Mauer AM, Ansari RH, Hoffman PC, Krauss SA, Taber D, Tembe SA, Gabrys GT, Cotter T, Schumm LP, Szeto L, Vokes EEAnnals of oncology : official journal of the European Society for Medical OncologyPhase I/II investigation of paclitaxel, ifosfamide and carboplatin for advanced non-small-cell lung cancer. Ann Oncol. 2003 May; 14(5):722-8.Ann Oncol2003-05-01T00:00:002003Phase I/II investigation of paclitaxel, ifosfamide and carboplatin for advanced non-small-cell lung cancer.14731323Vokes EE, Gordon GS, Mauer AM, Rudin CM, Krauss SA, Szeto L, Golomb HM, Hoffman PCClinical lung cancerA phase I study of STEALTH cisplatin (SPI-77) and vinorelbine in patients with advanced non small-cell lung cancer. Clin Lung Cancer. 2000 Nov; 2(2):128-32.Clin Lung Cancer2000-11-01T00:00:002000A phase I study of STEALTH cisplatin (SPI-77) and vinorelbine in patients with advanced non small-cell lung cancer.15292715Undevia SD, Vogelzang NJ, Mauer AM, Janisch L, Mani S, Ratain MJInvestigational new drugsPhase I clinical trial of CEP-2563 dihydrochloride, a receptor tyrosine kinase inhibitor, in patients with refractory solid tumors. Invest New Drugs. 2004 Nov; 22(4):449-58.Invest New Drugs2004-11-01T00:00:002004Phase I clinical trial of CEP-2563 dihydrochloride, a receptor tyrosine kinase inhibitor, in patients with refractory solid tumors.14662035Vokes EE, Charoentum C, Gordon GS, Rudin CM, Krauss SA, Hoffman PC, Mauer AM, Lee S, Watson SClinical lung cancerPhase I study of dose-dense alternating doublets in advanced non-small-cell lung cancer. Clin Lung Cancer. 2002 May; 3(4):265-70.Clin Lung Cancer2002-05-01T00:00:002002Phase I study of dose-dense alternating doublets in advanced non-small-cell lung cancer.15685037Gupta S, Mauer AM, Ryan CW, Taber DA, Samuels BL, Fleming GF, University of Chicago Phase II NetworkAmerican journal of clinical oncologyA phase II trial of UFT and leucovorin in women 65 years and older with advanced breast cancer. Am J Clin Oncol. 2005 Feb; 28(1):65-9.Am J Clin Oncol2005-02-01T00:00:002005A phase II trial of UFT and leucovorin in women 65 years and older with advanced breast cancer.Medicine-Hematology and Oncology18166842Choong NW, Vokes EE, Haraf DJ, Tothy PK, Ferguson MK, Kasza K, Rudin CM, Hoffman PC, Krauss SA, Szeto L, Mauer AMJournal of thoracic oncology : official publication of the International Association for the Study of Lung CancerPhase I study of induction chemotherapy and concomitant chemoradiotherapy with irinotecan, carboplatin, and paclitaxel for stage III non-small cell lung cancer. J Thorac Oncol. 2008 Jan; 3(1):59-67.J Thorac Oncol2008-01-01T00:00:002008Phase I study of induction chemotherapy and concomitant chemoradiotherapy with irinotecan, carboplatin, and paclitaxel for stage III non-small cell lung cancer.282457George SL, Aur RJ, Mauer AM, Simone JVThe New England journal of medicineA reappraisal of the results of stopping therapy in childhood leukemia. N Engl J Med. 1979 Feb 08; 300(6):269-73.N Engl J Med1979-02-08T00:00:001979A reappraisal of the results of stopping therapy in childhood leukemia.17305018Mauer AM, Rich ES, Schilsky RLCancer treatment and researchThe role of cooperative groups in cancer clinical trials. Cancer Treat Res. 2007; 132:111-29.Cancer Treat Res2007-01-01T00:00:002007The role of cooperative groups in cancer clinical trials.17409864Choong NW, Mauer AM, Hoffman PC, Rudin CM, Winegarden JD, Villano JL, Kozloff M, Wade JL, Sciortino DF, Szeto L, Vokes EEJournal of thoracic oncology : official publication of the International Association for the Study of Lung CancerPhase II trial of temozolomide and irinotecan as second-line treatment for advanced non-small cell lung cancer. J Thorac Oncol. 2006 Mar; 1(3):245-51.J Thorac Oncol2006-03-01T00:00:002006Phase II trial of temozolomide and irinotecan as second-line treatment for advanced non-small cell lung cancer.282003Rivera G, Murphy SB, Aur RJ, Verzosa MS, Dahl GV, Mauer AMCancerRecurrent childhood lymphocytic leukemia: clinical and cytokinetic studies of cytosine arabinoside and methotrexate for maintenance of second hematologic remission. Cancer. 1978 Dec; 42(6):2521-8.Cancer1978-12-01T00:00:001978Recurrent childhood lymphocytic leukemia: clinical and cytokinetic studies of cytosine arabinoside and methotrexate for maintenance of second hematologic remission.18978566Stinchcombe TE, Mauer AM, Hodgson LD, Herndon JE, Lynch TJ, Green MR, Vokes EE, Cancer and Leukemia Group BJournal of thoracic oncology : official publication of the International Association for the Study of Lung CancerPhase II trial of paclitaxel and cisplatin in patients with extensive stage small cell lung cancer: Cancer and Leukemia Group B Trial 9430. J Thorac Oncol. 2008 Nov; 3(11):1301-7.J Thorac Oncol2008-11-01T00:00:002008Phase II trial of paclitaxel and cisplatin in patients with extensive stage small cell lung cancer: Cancer and Leukemia Group B Trial 9430.18520803Mauer AM, Cohen EE, Ma PC, Kozloff MF, Schwartzberg L, Coates AI, Qian J, Hagey AE, Gordon GBJournal of thoracic oncology : official publication of the International Association for the Study of Lung CancerA phase II study of ABT-751 in patients with advanced non-small cell lung cancer. J Thorac Oncol. 2008 Jun; 3(6):631-6.J Thorac Oncol2008-06-01T00:00:002008A phase II study of ABT-751 in patients with advanced non-small cell lung cancer.17882655Seiwert TY, Cohen EE, Haraf DJ, Stenson K, Blair EA, Mauer A, Dekker A, Vokes EECancer investigationA phase I trial of docetaxel based induction and concomitant chemotherapy in patients with locally advanced head and neck cancer. Cancer Invest. 2007 Sep; 25(6):435-44.Cancer Invest2007-09-01T00:00:002007A phase I trial of docetaxel based induction and concomitant chemotherapy in patients with locally advanced head and neck cancer.18758303Choong NW, Mauer AM, Haraf DJ, Lester E, Hoffman PC, Kozloff M, Lin S, Dancey JE, Szeto L, Grushko T, Olopade OI, Salgia R, Vokes EEJournal of thoracic oncology : official publication of the International Association for the Study of Lung CancerPhase I trial of erlotinib-based multimodality therapy for inoperable stage III non-small cell lung cancer. J Thorac Oncol. 2008 Sep; 3(9):1003-11.J Thorac Oncol2008-09-01T00:00:002008Phase I trial of erlotinib-based multimodality therapy for inoperable stage III non-small cell lung cancer.15547705Mehta N, Mauer AM, Hellman S, Haraf DJ, Cohen EE, Vokes EE, Weichselbaum RRInternational journal of oncologyAnalysis of further disease progression in metastatic non-small cell lung cancer: implications for locoregional treatment. Int J Oncol. 2004 Dec; 25(6):1677-83.Int J Oncol2004-12-01T00:00:002004Analysis of further disease progression in metastatic non-small cell lung cancer: implications for locoregional treatment.D017239Chemicals & Drugs1164600.850636PaclitaxelMarina ChiaraGarassinoMarina Chiara Garassino41.7886000000000087.598699999999994025Garassino, Marina ChiaraProfessor15919687Mauer AM, Kraut EH, Krauss SA, Ansari RH, Kasza K, Szeto L, Vokes EEAnnals of oncology : official journal of the European Society for Medical OncologyPhase II trial of oxaliplatin, leucovorin and fluorouracil in patients with advanced carcinoma of the esophagus. Ann Oncol. 2005 Aug; 16(8):1320-5.Ann Oncol2005-05-26T00:00:002005Phase II trial of oxaliplatin, leucovorin and fluorouracil in patients with advanced carcinoma of the esophagus.17473657Buckingham LE, Coon JS, Morrison LE, Jacobson KK, Jewell SS, Kaiser KA, Mauer AM, Muzzafar T, Polowy C, Basu S, Gale M, Villaflor VM, Bonomi PJournal of thoracic oncology : official publication of the International Association for the Study of Lung CancerThe prognostic value of chromosome 7 polysomy in non-small cell lung cancer patients treated with gefitinib. J Thorac Oncol. 2007 May; 2(5):414-22.J Thorac Oncol2007-05-01T00:00:002007The prognostic value of chromosome 7 polysomy in non-small cell lung cancer patients treated with gefitinib.2630009Mauer AMCancer investigationThe biological basis of age in the determination of prognosis in acute lymphoblastic leukemia. Cancer Invest. 1989; 7(6):601-5.Cancer Invest1989-01-01T00:00:001989The biological basis of age in the determination of prognosis in acute lymphoblastic leukemia.267806Murphy SB, Mauer AMThe New England journal of medicineTerminal transferase and lymphoblastic neoplasms. N Engl J Med. 1977 Sep 01; 297(9):502-3.N Engl J Med1977-09-01T00:00:001977Terminal transferase and lymphoblastic neoplasms.3032414Hunter RF, Broadway P, Sun SL, Niell HB, Mauer AMCancer researchDetection of small cell lung cancer bone marrow involvement by discontinuous gradient sedimentation. Cancer Res. 1987 May 15; 47(10):2737-40.Cancer Res1987-05-15T00:00:001987Detection of small cell lung cancer bone marrow involvement by discontinuous gradient sedimentation.3459963Mauer AMThe New England journal of medicineNew directions in the treatment of acute lymphoblastic leukemia in children. N Engl J Med. 1986 Jul 31; 315(5):316-7.N Engl J Med1986-07-31T00:00:001986New directions in the treatment of acute lymphoblastic leukemia in children.6259530Brodeur GM, Pratt CB, Mauer AMThe New England journal of medicineCase 50-1980: mixed malignant germ-cell tumor. N Engl J Med. 1981 Apr 23; 304(17):1047-8.N Engl J Med1981-04-23T00:00:001981Case 50-1980: mixed malignant germ-cell tumor.3891922George SL, Ochs JJ, Mauer AM, Simone JVJournal of clinical oncology : official journal of the American Society of Clinical OncologyThe importance of an isolated central nervous system relapse in children with acute lymphoblastic leukemia. J Clin Oncol. 1985 Jun; 3(6):776-81.J Clin Oncol1985-06-01T00:00:001985The importance of an isolated central nervous system relapse in children with acute lymphoblastic leukemia.5286686Lampkin BC, Nagao T, Mauer AMThe Journal of clinical investigationSynchronization and recruitment in acute leukemia. J Clin Invest. 1971 Oct; 50(10):2204-14.J Clin Invest1971-10-01T00:00:001971Synchronization and recruitment in acute leukemia.4502317Lampkin BC, McWilliams NB, Mauer AMSeminars in hematologyCell kinetics and chemotherapy in acute leukemia. Semin Hematol. 1972 Apr; 9(2):211-23.Semin Hematol1972-04-01T00:00:001972Cell kinetics and chemotherapy in acute leukemia.4517030Mauer AM, Lampkin BC, McWilliams NBTransplantation proceedingsEffects of chemotherapeutic agents on cell cycle and cellular proliferation: basic and clinical considerations. Transplant Proc. 1973 Sep; 5(3):1181-4.Transplant Proc1973-09-01T00:00:001973Effects of chemotherapeutic agents on cell cycle and cellular proliferation: basic and clinical considerations.6896834Dahl GV, Kalwinsky DK, Murphy S, Look AT, Amadori S, Kumar M, Novak R, George SL, Mason C, Mauer AM, Simone JVBloodCytokinetically based induction chemotherapy and splenectomy for childhood acute nonlymphocytic leukemia. Blood. 1982 Oct; 60(4):856-63.Blood1982-10-01T00:00:001982Cytokinetically based induction chemotherapy and splenectomy for childhood acute nonlymphocytic leukemia.7022217Ackerman TF, Mauer AMThe New England journal of medicineSounding board. Compensation and cancer research. N Engl J Med. 1981 Sep 24; 305(13):760-3.N Engl J Med1981-09-24T00:00:001981Sounding board. Compensation and cancer research.4168739Canales ML, Mauer AMThe New England journal of medicineSex-linked hereditary thrombocytopenia as a variant of Wiskott-Aldrich syndrome. N Engl J Med. 1967 Oct 26; 277(17):899-901.N Engl J Med1967-10-26T00:00:001967Sex-linked hereditary thrombocytopenia as a variant of Wiskott-Aldrich syndrome.7552815Miller AA, Mauer AM, Tolley EACancer investigationDosing of oral etoposide normalized for body surface area. Cancer Invest. 1995; 13(5):487-91.Cancer Invest1995-01-01T00:00:001995Dosing of oral etoposide normalized for body surface area.5470848Wriedt K, Kauder E, Mauer AMThe New England journal of medicineDefective myelopoiesis in congenital neutropenia. N Engl J Med. 1970 Nov 12; 283(20):1072-7.N Engl J Med1970-11-12T00:00:001970Defective myelopoiesis in congenital neutropenia.5785754Nagao T, Mauer AMThe New England journal of medicineConcordance for drug-induced aplastic anemia in identical twins. N Engl J Med. 1969 Jul 03; 281(1):7-11.N Engl J Med1969-07-03T00:00:001969Concordance for drug-induced aplastic anemia in identical twins.19208430Kim ES, Mauer AM, William WN, Tran HT, Liu D, Lee JJ, Windt P, Hong WK, Vokes EE, Herbst RSCancerA phase 2 study of cetuximab in combination with docetaxel in chemotherapy-refractory/resistant patients with advanced nonsmall cell lung cancer. Cancer. 2009 Apr 15; 115(8):1713-22.Cancer2009-04-15T00:00:002009A phase 2 study of cetuximab in combination with docetaxel in chemotherapy-refractory/resistant patients with advanced nonsmall cell lung cancer.19439741Muss HB, Berry DA, Cirrincione CT, Theodoulou M, Mauer AM, Kornblith AB, Partridge AH, Dressler LG, Cohen HJ, Becker HP, Kartcheske PA, Wheeler JD, Perez EA, Wolff AC, Gralow JR, Burstein HJ, Mahmood AA, Magrinat G, Magrinat G, Parker BA, Hart RD, Grenier D, Norton L, Hudis CA, Winer EP, CALGB InvestigatorsThe New England journal of medicineAdjuvant chemotherapy in older women with early-stage breast cancer. N Engl J Med. 2009 May 14; 360(20):2055-65.N Engl J Med2009-05-14T00:00:002009Adjuvant chemotherapy in older women with early-stage breast cancer.20730572Choong NW, Mauer AM, Haraf DC, Ferguson MK, Sandler AB, Kesler KA, Fishkin PA, Ansari RH, Wade J, Krauss SA, Sciortino DF, Posner MC, Kocherginsky M, Hoffman PC, Szeto L, Vokes EEMedical oncology (Northwood, London, England)Long-term outcome of a phase II study of docetaxel-based multimodality chemoradiotherapy for locally advanced carcinoma of the esophagus or gastroesophageal junction. Med Oncol. 2011 Dec; 28 Suppl 1:S152-61.Med Oncol2010-08-21T00:00:002010Long-term outcome of a phase II study of docetaxel-based multimodality chemoradiotherapy for locally advanced carcinoma of the esophagus or gastroesophageal junction.4129798Strauss RG, Bove KE, Jones JF, Mauer AM, Fulginiti VAThe New England journal of medicineAn anomaly of neutrophil morphology with impaired function. N Engl J Med. 1974 Feb 28; 290(9):478-84.N Engl J Med1974-02-28T00:00:001974An anomaly of neutrophil morphology with impaired function.908020Hayes FA, Green AA, Mauer AMCancer researchCorrelation of cell kinetic and clinical response to chemotherapy in disseminated neuroblastoma. Cancer Res. 1977 Oct; 37(10):3766-70.Cancer Res1977-10-01T00:00:001977Correlation of cell kinetic and clinical response to chemotherapy in disseminated neuroblastoma.7037164Evans WE, Tsiatis A, Rivera G, Murphy SB, Dahl GV, Denison M, Crom WR, Barker LF, Mauer AMCancerAnaphylactoid reactions to Escherichia coli and Erwinia asparaginase in children with leukemia and lymphoma. Cancer. 1982 Apr 01; 49(7):1378-83.Cancer1982-04-01T00:00:001982Anaphylactoid reactions to Escherichia coli and Erwinia asparaginase in children with leukemia and lymphoma.1187606Mauer AM, Murphy SBThe Proceedings of the Institute of Medicine of ChicagoCell kinetics and practical consequences for therapy of acute leukemia. Proc Inst Med Chic. 1975 Jul-Sep; 30(8):247-50.Proc Inst Med Chic1975-07-01T00:00:001975Cell kinetics and practical consequences for therapy of acute leukemia.9704674Vokes EE, Mauer AM, Hoffman PC, Haraf DJSeminars in oncologyCombined modality therapy in non-small cell lung and esophageal cancer: a phase I dose-escalation study of docetaxel with concurrent radiotherapy. Semin Oncol. 1998 Jun; 25(3 Suppl 8):28-32.Semin Oncol1998-06-01T00:00:001998Combined modality therapy in non-small cell lung and esophageal cancer: a phase I dose-escalation study of docetaxel with concurrent radiotherapy.12581572Winegarden JD, Mauer AM, Gajewski TF, Hoffman PC, Krauss S, Rudin CM, Vokes EELung cancer (Amsterdam, Netherlands)A phase II study of bryostatin-1 and paclitaxel in patients with advanced non-small cell lung cancer. Lung Cancer. 2003 Feb; 39(2):191-6.Lung Cancer2003-02-01T00:00:002003A phase II study of bryostatin-1 and paclitaxel in patients with advanced non-small cell lung cancer.12649117Villano JL, Mauer AM, Vokes EEAnnals of oncology : official journal of the European Society for Medical OncologyA case study documenting the anticancer activity of ZD1839 (Iressa) in the brain. Ann Oncol. 2003 Apr; 14(4):656-8.Ann Oncol2003-04-01T00:00:002003A case study documenting the anticancer activity of ZD1839 (Iressa) in the brain.15151948Winegarden JD, Mauer AM, Otterson GA, Rudin CM, Villalona-Calero MA, Lanzotti VJ, Szeto L, Kasza K, Hoffman PC, Vokes EE, University of Chicago Phase II Network, Ohio State UniversityAnnals of oncology : official journal of the European Society for Medical OncologyA phase II study of oxaliplatin and paclitaxel in patients with advanced non-small-cell lung cancer. Ann Oncol. 2004 Jun; 15(6):915-20.Ann Oncol2004-06-01T00:00:002004A phase II study of oxaliplatin and paclitaxel in patients with advanced non-small-cell lung cancer.16322304Cohen EE, Kane MA, List MA, Brockstein BE, Mehrotra B, Huo D, Mauer AM, Pierce C, Dekker A, Vokes EEClinical cancer research : an official journal of the American Association for Cancer ResearchPhase II trial of gefitinib 250 mg daily in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck. Clin Cancer Res. 2005 Dec 01; 11(23):8418-24.Clin Cancer Res2005-12-01T00:00:002005Phase II trial of gefitinib 250 mg daily in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck.17255273Seiwert TY, Connell PP, Mauer AM, Hoffman PC, George CM, Szeto L, Salgia R, Posther KE, Nguyen B, Haraf DJ, Vokes EEClinical cancer research : an official journal of the American Association for Cancer ResearchA phase I study of pemetrexed, carboplatin, and concurrent radiotherapy in patients with locally advanced or metastatic non-small cell lung or esophageal cancer. Clin Cancer Res. 2007 Jan 15; 13(2 Pt 1):515-22.Clin Cancer Res2007-01-15T00:00:002007A phase I study of pemetrexed, carboplatin, and concurrent radiotherapy in patients with locally advanced or metastatic non-small cell lung or esophageal cancer.18281656Edelman MJ, Watson D, Wang X, Morrison C, Kratzke RA, Jewell S, Hodgson L, Mauer AM, Gajra A, Masters GA, Bedor M, Vokes EE, Green MJJournal of clinical oncology : official journal of the American Society of Clinical OncologyEicosanoid modulation in advanced lung cancer: cyclooxygenase-2 expression is a positive predictive factor for celecoxib + chemotherapy--Cancer and Leukemia Group B Trial 30203. J Clin Oncol. 2008 Feb 20; 26(6):848-55.J Clin Oncol2008-02-20T00:00:002008Eicosanoid modulation in advanced lung cancer: cyclooxygenase-2 expression is a positive predictive factor for celecoxib + chemotherapy--Cancer and Leukemia Group B Trial 30203.3114285Mauer AMHospital practice (Office ed.)Acute lymphoblastic leukemia in a young adult. Hosp Pract (Off Ed). 1987 Sep 15; 22(9):145-50, 155-62.Hosp Pract (Off Ed)1987-09-15T00:00:001987Acute lymphoblastic leukemia in a young adult.7115962Look AT, Melvin SL, Williams DL, Brodeur GM, Dahl GV, Kalwinsky DK, Murphy SB, Mauer AMBloodAneuploidy and percentage of S-phase cells determined by flow cytometry correlate with cell phenotype in childhood acute leukemia. Blood. 1982 Oct; 60(4):959-67.Blood1982-10-01T00:00:001982Aneuploidy and percentage of S-phase cells determined by flow cytometry correlate with cell phenotype in childhood acute leukemia.D004938Disorders1003200.803416Esophageal NeoplasmsMedicineRadiologySurgeryUniversity of ChicagoPhilip CharlesHoffmanPhilip Charles Hoffman41.78927490000000-87.601250000000001014Hoffman, Philip CharlesClinical Professor1.238710.00160664348research areas0.9087250.014422524coauthor of77.19075.5188260similar to1185selected publicationsAlainLabroAlain J. Labro41.78927490000000-87.601250000000001296Labro, AlainEzraCohenEzra Cohen41.78927490000000-87.601250000000001350Cohen, EzraASSOCIATE PROFESSORMark J.RatainMark J. Ratain41.78927490000000-87.601250000000001401Ratain, Mark J.ProfessorEverett E.VokesEverett E. Vokes41.78927490000000-87.601250000000001920Vokes, Everett E.ProfessorRaviSalgiaRavi Salgia41.78927490000000-87.601250000000001937Salgia, RaviEmeritus/Emerita, ProfessorRichardSchilskyRichard Schilsky41.78927490000000-87.601250000000002119Schilsky, RichardProfessor EmeritusStephenVogelStephen Vogel41.78927490000000-87.6012500000000024Vogel, StephenBrian C.CallenderBrian C. Callender41.78927490000000-87.60125000000000384Callender, Brian C.Associate ProfessorDan LiviuNicolaeDan Liviu Nicolae41.78927490000000-87.60125000000000578Nicolae, Dan LiviuProfessorBrian S.FunakiBrian S. Funaki41.78927490000000-87.60125000000000729Funaki, Brian S.ProfessorDaniel J.HarafDaniel J. Haraf41.78927490000000-87.60125000000000928Haraf, Daniel J.Clinical Professortrue1true1true1true1ASSOCIATE PROFESSORASSOCIATE PROFESSORtrue1Emeritus/Emerita, ProfessorEmeritus/Emerita, Professortrue1ProfessorProfessortrue1Professor EmeritusProfessor Emeritustrue1Clinical ProfessorClinical Professortrue1ProfessorProfessortrue1ProfessorProfessortrue1Associate ProfessorAssociate Professortrue1Clinical ProfessorClinical Professortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessorChicago60637ILAuthorship 933311327524614Chillo O, Kleinert EC, Lautz T, Lasch M, Pagel JI, Heun Y, Troidl K, Fischer S, Caballero-Martinez A, Mauer A, Kurz ARM, Assmann G, Rehberg M, Kanse SM, Nieswandt B, Walzog B, Reichel CA, Mannell H, Preissner KT, Deindl ECell reportsPerivascular Mast Cells Govern Shear Stress-Induced Arteriogenesis by Orchestrating Leukocyte Function. Cell Rep. 2016 08 23; 16(8):2197-2207.Cell Rep2016-08-11T00:00:002016Perivascular Mast Cells Govern Shear Stress-Induced Arteriogenesis by Orchestrating Leukocyte Function.Statistics Authorship 499784Authorship 501333Authorship 499621Authorship 501291Authorship 501242Authorship 517533Authorship 515451Authorship 525891Authorship 519727Authorship 516432Authorship 5635631026338Mauer AM, Murphy SB, Hayes FACancer treatment reportsEvidence for recruitment and synchronization in leukemia and solid tumors. Cancer Treat Rep. 1976 Dec; 60(12):1841-4.Cancer Treat Rep1976-12-01T00:00:001976Evidence for recruitment and synchronization in leukemia and solid tumors.1063031Lampkin BC, McWilliams NB, Mauer AM, Flessa HC, Hake DA, Fisher VBritish journal of haematologyManipulation of the mitotic cycle in the treatment of acute myelogenous leukaemia. Br J Haematol. 1976 Jan; 32(1):29-40.Br J Haematol1976-01-01T00:00:001976Manipulation of the mitotic cycle in the treatment of acute myelogenous leukaemia.263871Pratt CB, Smith JW, Woerner S, Mauer AM, Hustu HO, Johnson WW, Shanks ECPediatricsFactors leading to delay in the diagnosis and affecting survival of children with head and neck rhabdomyosarcoma. Pediatrics. 1978 Jan; 61(1):30-4.Pediatrics1978-01-01T00:00:001978Factors leading to delay in the diagnosis and affecting survival of children with head and neck rhabdomyosarcoma.198732Mauer AMPediatric researchRecent advances in pediatric oncology. Pediatr Res. 1977 Sep; 11(9 Pt 2):1008-10.Pediatr Res1977-09-01T00:00:001977Recent advances in pediatric oncology.978773Hayes FA, Mauer AMJournal of the National Cancer InstituteCell kinetics and chemotherapy in neuroblastoma. J Natl Cancer Inst. 1976 Sep; 57(3):697-9.J Natl Cancer Inst1976-09-01T00:00:001976Cell kinetics and chemotherapy in neuroblastoma.5223200Mauer AM, Fisher VBloodCharacteristics of cell proliferation in four patients with untreated acute leukemia. Blood. 1966 Sep; 28(3):428-45.Blood1966-09-01T00:00:001966Characteristics of cell proliferation in four patients with untreated acute leukemia.6026877Lampkin BC, Mauer AM, McBride BHPediatricsResponse of medulloblastoma to vincristine sulfate: a case report. Pediatrics. 1967 May; 39(5):761-3.Pediatrics1967-05-01T00:00:001967Response of medulloblastoma to vincristine sulfate: a case report.7154706Murphy SB, Dahl GV, George SL, Karas J, Look AT, Simone JV, Mauer AMLeukemia researchDetermination of the significance of in vitro blast cell [3H]thymidine labelling indices obtained initially and serially during induction therapy of acute non-lymphocytic leukemia. Leuk Res. 1982; 6(5):639-48.Leuk Res1982-01-01T00:00:001982Determination of the significance of in vitro blast cell [3H]thymidine labelling indices obtained initially and serially during induction therapy of acute non-lymphocytic leukemia.6369925Thompson EI, Callihan TR, Mauer AMAdvances in internal medicineProphylaxis in severe granulocytopenia. Adv Intern Med. 1984; 29:193-214.Adv Intern Med1984-01-01T00:00:001984Prophylaxis in severe granulocytopenia.8416287Mauer AMAmerican journal of hematologyAdult and childhood acute lymphocytic leukemia: are they different diseases? Am J Hematol. 1993 Jan; 42(1):127-31.Am J Hematol1993-01-01T00:00:001993Adult and childhood acute lymphocytic leukemia: are they different diseases?16695924Saunders EF, Lampkin BC, Mauer AMThe Journal of clinical investigationVariation of proliferative activity in leukemic cell populations of patients with acute leukemia. J Clin Invest. 1967 Aug; 46(8):1356-63.J Clin Invest1967-08-01T00:00:001967Variation of proliferative activity in leukemic cell populations of patients with acute leukemia.